{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:46:13Z","timestamp":1793317573537,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.chroma.2024.465565","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T07:50:00Z","timestamp":1732866600000},"page":"465565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Impact of non-ionic surfactants on release kinetics, toxicity and colloidal characteristics of benznidazole self-emulsifying delivery system evidenced by flow field-flow fractionation"],"prefix":"10.1016","volume":"1740","author":[{"given":"L\u00edliam Teixeira","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Gomes","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M\u00e1rio Carneiro","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareth Spangler","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-0199","authenticated-orcid":false,"given":"Maria Alice","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-6090","authenticated-orcid":false,"given":"Vanessa Carla Furtado","family":"Mosqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2024.465565_bib0001","series-title":"Dr. Inamuddin; Fabio Rocha Formiga; Patr\u00edcia Severino. (Org.). Applications of Nanobiotechnology for Neglected Tropical Diseases 1st Edition -466 pg. 1\u00aaed","first-page":"1","article-title":"Nanomedicines against Chagas disease","author":"Mosqueira","year":"2020"},{"key":"10.1016\/j.chroma.2024.465565_bib0002","unstructured":"WHO World Health Organization. Chagas disease (American trypanosomiasis), WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis) (accessed September 14, 2024)."},{"key":"10.1016\/j.chroma.2024.465565_bib0003","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","article-title":"Chagas disease: from discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","journal-title":"Front. Public Health"},{"key":"10.1016\/j.chroma.2024.465565_bib0004","unstructured":"C. for D.E. and Research, Drug trials snapshot: BENZNIDAZOLE, FDA. (2019). http:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshot-benznidazole (accessed July 6, 2019)."},{"key":"10.1016\/j.chroma.2024.465565_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"E1224 study group, treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.chroma.2024.465565_bib0006","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chroma.2024.465565_bib0007","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/13543784.2024.2349289","article-title":"Drugs in preclinical and early clinical development for the treatment of Chagas\u00b4s disease: the current status","volume":"33","author":"Torchelsen","year":"2024","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.chroma.2024.465565_bib0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","article-title":"Role of biopharmaceutics classification system and BDDCS biopharmaceutics drug disposition classification system in drug development","volume":"102","author":"Benet","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0009","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/bcp.13650","article-title":"Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system","volume":"84","author":"del Moral Sanchez","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.chroma.2024.465565_bib0010","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.00689-15","article-title":"Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease","volume":"59","author":"Khare","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chroma.2024.465565_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chroma.2024.465565_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chroma.2024.465565_bib0013","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4274\/tjps.galenos.2021.73554","article-title":"Emerging role of biopharmaceutical classification and biopharmaceutical drug disposition system in dosage form development: a systematic review","volume":"19","author":"Samineni","year":"2022","journal-title":"Turk. J. Pharm. Sci."},{"issue":"1\u201312","key":"10.1016\/j.chroma.2024.465565_bib0014","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1208\/s12249-019-1335-x","article-title":"Self-emulsifying oral lipid drug delivery systems: advances and challenges","volume":"20","author":"Rani","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"2013","key":"10.1016\/j.chroma.2024.465565_bib0015","article-title":"Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems","author":"Gupta","year":"2013","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.chroma.2024.465565_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105234","article-title":"Benznidazole self-emulsifying delivery system: a novel alternative dosage form for chagas disease treatment","volume":"145","author":"Mazzeti","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0017","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/03639045.2017.1342654","article-title":"Review and analysis of FDA-approved drugs using lipid-based formulations","volume":"43","author":"Savla","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.chroma.2024.465565_bib0018","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.2015.999038","article-title":"Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects","volume":"12","author":"Cherniakov","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"12","key":"10.1016\/j.chroma.2024.465565_bib0019","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.2147\/IJN.S133708","article-title":"Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity","volume":"12","author":"Sp\u00f3sito","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.chroma.2024.465565_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2021.108142","article-title":"Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental Chagas disease","volume":"228","author":"Sp\u00f3sito","year":"2021","journal-title":"Exp. Parasit."},{"key":"10.1016\/j.chroma.2024.465565_bib0021","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02976689","article-title":"Commonly used surfactant, tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats","volume":"26","author":"Zhang","year":"2003","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.chroma.2024.465565_bib0022","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jps.10395","article-title":"The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins","volume":"92","author":"Bogman","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0023","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/jps.21836","article-title":"Absorption barriers in the rat intestinal mucosa. 3: effects of polyethoxylated solubilizing agents on drug permeation and metabolism","volume":"99","author":"Mudra","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0024","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1021\/acs.molpharmaceut.8b00482","article-title":"Inhibitory effects of commonly used excipients on P-glycoprotein in vitro","volume":"15","author":"Gurjar","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chroma.2024.465565_bib0025","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/AAC.02531-12","article-title":"Modulation of biotransformation systems and ABC transporters by benznidazole in rats","volume":"57","author":"Perdomo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.chroma.2024.465565_bib0026","doi-asserted-by":"crossref","first-page":"e1951","DOI":"10.1371\/journal.pntd.0001951","article-title":"Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor","volume":"6","author":"Rigalli","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.chroma.2024.465565_bib0027","first-page":"477","article-title":"Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells","volume":"24","author":"Sha","year":"2005","journal-title":"Sciences"},{"key":"10.1016\/j.chroma.2024.465565_bib0028","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.30.1301","article-title":"Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats","volume":"30","author":"Lin","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.chroma.2024.465565_bib0029","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2016.10.012","article-title":"In-vitro investigation regarding the effects of Gelucire\u00ae 44\/14 and Labrasol\u00ae ALF on the secretory intestinal transport of P-gp substrates","volume":"515","author":"Dubray","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chroma.2024.465565_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40005-018-0385-5","article-title":"Canagliflozin loaded SMEDDS: formulation optimization for improved solubility, permeability and pharmacokinetic performance","volume":"49","author":"Singh","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.chroma.2024.465565_bib0031","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcis.2012.02.063","article-title":"Study of nanoemulsion formation by dilution of microemulsions","volume":"376","author":"Sol\u00e8","year":"2012","journal-title":"J. Coll. Interf. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0032","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/01496397808057119","article-title":"Steric field-flow fractionation: a new method for separating I to 100 \u03bcm Particles","volume":"13","author":"Giddings","year":"1978","journal-title":"Sep. Sci. Technol."},{"key":"10.1016\/j.chroma.2024.465565_bib0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.chroma.2024.465565_bib0034","unstructured":"BRASIL. Resolu\u00e7\u00e3o Normativa n\u00b0 30, de 2 de fevereiro de 2016. Dispon\u00edvel em: https:\/\/www.in.gov.br\/web\/guest\/materia\/-\/asset_publisher\/Kujrw0TZC2Mb\/content\/id\/21168861\/do1-2016-02-03-resolucao-normativa-n-30-de-2-de-fevereiro-de-2016-21168787. (Accessed 31 jul. 2022)."},{"key":"10.1016\/j.chroma.2024.465565_bib0035","series-title":"Test No. 423: Acute Oral Toxicity - Acute Toxic Class Method. OECD Guidelines for Testing Chemicals, Section 4","year":"2002"},{"key":"10.1016\/j.chroma.2024.465565_bib0036","unstructured":"ICH Topic M3(M), 2000. ICH harmonized tripartite guidelines. Guidance for industry. Nonclinical studies for the safety evaluation of pharmaceutical excipients. https:\/\/www.fda.gov\/media\/72260\/download. (accessed on 14 September 2024)."},{"key":"10.1016\/j.chroma.2024.465565_bib0037","series-title":"Handbook of Pharmaceutical Excipients. 6th. Ed","author":"Rowe","year":"2009"},{"key":"10.1016\/j.chroma.2024.465565_bib0038","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejps.2012.07.005","article-title":"Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer","volume":"47","author":"Ujhelyi","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0039","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1208\/s12249-014-0078-y","article-title":"Self-nanoemulsifying drug delivery system of nifedipine: impact of hydrophilic-lipophilic balance and molecular structure of mixed surfactants","volume":"15","author":"Weerapo","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.chroma.2024.465565_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cocis.2016.03.002","article-title":"Spontaneous emulsification","volume":"22","author":"Solans","year":"2016","journal-title":"Curr. Opinion Coll. Interf. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0041","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41578-019-0161-9","article-title":"Multiple nanoemulsions","volume":"5","author":"Sheth","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.chroma.2024.465565_bib0042","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.foodhyd.2012.04.009","article-title":"Fabrication of ultrafine edible emulsions: comparison of high-energy and low-energy homogenization methods","volume":"29","author":"Yang","year":"2012","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.chroma.2024.465565_bib0043","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2015.04.033","article-title":"Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation","volume":"209","author":"Garcia","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.chroma.2024.465565_bib0044","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejps.2017.04.017","article-title":"Impact of dose and surface features on plasmatic and liver concentrations of biodegradable polymeric nanocapsules","volume":"105","author":"Oliveira","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/(SICI)1520-6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7","article-title":"Poly(D,L-lactide) nanocapsules prepared by solvent displacement process: influence of composition on physicochemical and structural properties","volume":"89","author":"Mosqueira","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0046","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1023\/A:1011968313933","article-title":"Interaction of the self-emulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size","volume":"15","author":"Gershanik","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chroma.2024.465565_bib0047","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejps.2006.04.016","article-title":"Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system","volume":"29","author":"Pouton","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0048","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0001-8686(03)00108-8","article-title":"Formation and properties of miniemulsions formed by microemulsions dilution","volume":"106","author":"Pons","year":"2003","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0049","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/jssc.200800626","article-title":"Asymmetric flow field-flow fractionation of liposomes: optimization of fractionation variables","volume":"32","author":"Hupfeld","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.461959","article-title":"Release, transfer and partition of fluorescent dyes from polymeric nanocarriers to serum proteins monitored by asymmetric flow field-flow fractionation","volume":"1641","author":"Oliveira","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2024.465565_bib0051","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ab.2008.02.011","article-title":"Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering","volume":"376","author":"Citkowicz","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2024.465565_bib0052","doi-asserted-by":"crossref","first-page":"13882","DOI":"10.1021\/acsomega.8b02311","article-title":"Encapsulation and delivery of neutrophic proteins and hydrophobic agents using PMOXA\u2212PDMS\u2212PMOXA triblock polymersomes","volume":"3","author":"Moquin","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.chroma.2024.465565_bib0053","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2003.11.012","article-title":"Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy","volume":"95","author":"Jores","year":"2004","journal-title":"J. Control Release"},{"key":"10.1016\/j.chroma.2024.465565_bib0054","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1021\/ac030128+","article-title":"Accuracy in multiangle light scattering measurements for molar mass and radius estimations. Model calculations and experiments","volume":"75","author":"Andersson","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2024.465565_bib0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jssc.202100595","article-title":"Field-flow fractionation for nanoparticle characterization","volume":"45","author":"Lespes","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0056","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2019.01.008","article-title":"Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs","volume":"142","author":"Vithani","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chroma.2024.465565_bib0057","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/09553007914550151","article-title":"Structure-activity relationships in the development of hypoxic cell radiosensitizers","volume":"35","author":"Adams","year":"1979","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.chroma.2024.465565_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105177","article-title":"Transbuccal delivery of benznidazole associated with monoterpenes: permeation studies and mechanistic insights","volume":"143","author":"Amaral","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2024.465565_bib0059","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejps.2009.09.012","article-title":"Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS","volume":"38","author":"Thi","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.chroma.2024.465565_bib0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0300-483X(80)90056-6","article-title":"Biological effects of surfactants, IV. Effects of non-ionics and amphoterics on HeLa cells","volume":"15","author":"Ernst","year":"1980","journal-title":"Toxicology"},{"key":"10.1016\/j.chroma.2024.465565_bib0061","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2011.03.056","article-title":"Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells","volume":"411","author":"Maupas","year":"2011","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967324009385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967324009385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T09:05:41Z","timestamp":1735463141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967324009385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":61,"alternative-id":["S0021967324009385"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2024.465565","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of non-ionic surfactants on release kinetics, toxicity and colloidal characteristics of benznidazole self-emulsifying delivery system evidenced by flow field-flow fractionation","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2024.465565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"465565"}}